Proto Labs 10-Qquarter ended 2026-06-30

PositiveRestructuringImpairment / charge

Larger strategic accounts and aerospace and defense demand drive machining and injection-molding growth; Europe’s losses widen despite higher sales.

Filed 2026-07-31 15:11 ET

Key figures · Q2 FY2026 · period ended 2026-06-30

  • Revenue$149.3MYoY +10.6%
  • Operating income$11.4MYoY +128.6%
  • Net income$9.2MYoY +106.7%
  • Total assets$791.3M
  • Total debt$127.0K
  • Shareholders' equity$691.7MYoY +4.1%
  • Tangible book value$401.1M
Notes on other figures in this summary (1)
  • Cash and cash equivalents: Summary: $163M · Filing: $127.9M

    Comment from AI: The summary's $163M is cash and marketable securities; the claim's $127.9M is cash and cash equivalents, excluding marketable securities.

How this filing reads

  • Health+0.8Cash and marketable securities were $163M, with $33M of H1 operating cash flow.
  • Momentum+0.8Q2 revenue rose 11%, gross margin expanded 2.1 points, and operating income rose 129%.
  • Outlook0.0Management plans to reinvest savings, while Europe’s $6.6M operating loss widened 32%.
  • Restructuring“German facility closures contributed $0.937M of Q2 exit and disposal costs”
  • Impairment / charge“a $0.9M write-down of an abandoned facility’s lease asset”

Executive Summary

Proto Labs earns revenue manufacturing custom parts for business customers, including aerospace and defense companies, through machining, injection molding, 3D printing and sheet-metal services. Management is concentrating on larger, more strategic customers while investing in production capacity, automation and digital capabilities. Q2 revenue grew 11% to $149M as stronger machining and molding demand, pricing and production efficiency lifted operating margin to 7.6%. The opportunity is to deepen those customer relationships while improving factory economics; the main challenge is turning around Europe, where losses widened despite higher sales.

What's Happening in the Business

  • Customer strategy: Unique customer contacts fell 5.3% to 20,630 in Q2, while revenue per contact rose 17% to $7,239. Management attributes this to customer mix and its deliberate focus on larger strategic accounts, so growth came from more spending per contact rather than broader customer reach.
  • U.S. demand: Aerospace and defense customers helped drive machining and injection-molding growth, alongside market-driven price increases. These businesses—not 3D printing—provided the quarter’s expansion.
  • European restructuring: German facility closures contributed $0.937M of Q2 exit and disposal costs, including a $0.9M write-down of an abandoned facility’s lease asset. Management expects restructuring savings to be reinvested mainly in technology, automation and digital capabilities rather than retained entirely as cost reductions.
  • Technology and capacity: Management is pursuing artificial-intelligence applications in pricing, sourcing, inspection, toolpath verification and software development. These initiatives support its stated goals of improving customer experience and operating efficiency; the filing does not quantify their separate financial contribution.

Key Financial Highlights

Metric Q2 2026 H1 2026 Investor interpretation
Revenue $149M; +11% Y/Y $289M; +11% Y/Y Machining and molding demand, pricing and higher spending per customer contact drove growth.
Gross margin 46.4% vs 44.3% 46.0% vs 44.2% Production costs increased more slowly than sales, improving manufacturing economics.
Operating income $11.4M; +129% Y/Y $21.2M; +123% Y/Y Higher gross profit outpaced operating-expense growth despite restructuring and closure charges.
Net income $9.15M; +107% Y/Y $17.3M; +115% Y/Y Lower tax rates helped earnings, while reduced other income partly offset that benefit.
Operating cash flow — $33.0M vs $29.0M Noncash expenses supported cash flow above earnings, while working-capital and other operating movements absorbed cash.
Segment Q2 revenue Q2 operating income / (loss)
United States $120M; +11% Y/Y $38M; +36% Y/Y
Europe $27M; +9.2% Y/Y $(6.6)M; loss widened 32% Y/Y
  • Product drivers: Computer numerical control machining revenue was $70.4M, +14% Y/Y; injection molding was $53.6M, +13%. Together they supplied nearly all the dollar growth, while 3D printing revenue declined 2.6% to $20.7M.
  • Regional profitability: U.S. operating gains carried the company. Europe’s loss widened even with higher revenue, reflecting weaker underlying economics and restructuring-related costs.
  • Earnings quality: The Q2 effective tax rate fell to 27.4% from 33.7%, mainly because of benefits from equity-award vesting and option exercises. This helped reported earnings but was not an operating improvement.
  • Cash and reinvestment: H1 net income of $17.3M translated into $33.0M of operating cash flow, supported by $16.2M of depreciation and amortization and $7.31M of stock-based compensation. Gross capital purchases rose to $9.74M from $2.73M; cash and marketable securities totaled $163M at quarter-end, providing substantial funding capacity.
  • Capital returns and dilution: H1 repurchases fell to $5.04M from $24.0M, while shares outstanding increased 1.2% from year-end. Buybacks therefore did not offset equity issuance.

Risk Assessment

  • European turnaround: Europe’s widening operating loss and German facility closures show that revenue growth alone has not restored profitability; further disruption or unsuccessful restructuring could continue to consume U.S. earnings.
  • Unhedged currency exposure: Revenue, production and operating costs denominated mainly in pounds and euros expose earnings to exchange-rate movements; Q2 recorded a $0.2M currency loss versus a $0.5M gain a year earlier, even as translation helped revenue.

This 10-Q lists no risk factors of its own and refers to the annual report. The risks above come from the rest of this filing. Full list: the company's 10-Ks on SEC.

What to Watch

  • Strategic-customer growth: Revenue per contact is rising while contact counts shrink, supported by aerospace and defense demand for machining and molding. Later filings should show whether deeper relationships sustain sales growth or whether spending from those accounts weakens.
  • European recovery: Facility closures and restructuring are under way, but losses widened this quarter. Success would appear as narrower segment losses while revenue holds or grows; continued losses or further closures would challenge the turnaround.
  • Returns on production and technology spending: Capital purchases increased sharply, and management intends to reinvest restructuring savings in automation and digital capabilities. Improving gross margins alongside sustained revenue growth would support the investment case; spending without better operating performance would weaken it.

Longer version: the summary of each of the report's 6 sections, written by an AI model from the same filing.

What happened since

In the Q3 FY2026 10-Q:

  1. Watch item improved European recovery
    Q2 Europe lost $6.6M on $27M revenue; recovery required narrower losses alongside sustained sales. → Q3 loss narrowed to $3.35M on $28.9M revenue, though still wider year over year.
  2. Watch item mixed Production and technology investment
    Q2 gross margin reached 46.4% on 11% sales growth; H1 capital spending was $9.74M. → Q3 gross margin slipped to 44.5% despite 14% sales growth; 9M capital spending reached $15.5M.

Was this summary useful?

Figures are computed from the filing's XBRL data; the summary and scores are written by an AI model reading the filing.

Model 006 · prompt v130 · 2026-10-27 20:11:15Z

Feedback